Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...
Fresenius Kabi has introduced two new products in its Simplist portfolio of ready-to-administer prefilled syringes: Simplist ...
MannKind Corporation beats Q3 estimates and sees FDA progress on ReadyFlow Autoinjector, presenting strong revenue growth potential. Learn more about MNKD stock here.
MannKind (Nasdaq:MNKD) announced that the FDA accepted a supplemental New Drug Application (sNDA) for its Furoscix ReadyFlow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback